Thunen Shelley B
LENZ Therapeutics, Inc. · Director
Thunen Shelley B is listed in filings as Director at LENZ Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 11, 2025, including sale activity. Recent filings connect the profile to LENZ Therapeutics, Inc. (LENZ), AEON Biopharma, Inc. (AEON), and RxSight, Inc. (RXST). The current snapshot covers public activity from Jul 2, 2024 to Jun 11, 2025. Reported amounts are shown as $405.0K to $6.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $464k9.5k shares | SellOct 1, 2024 | $48.69 | $5.57 | |
| $249k5.2k shares | SellOct 1, 2024 | $47.96 | $5.57 | |
| $14k278 shares | SellOct 1, 2024 | $49.45 | $5.57 |